Anthi Panara

Anthi Panara

Auto-generated profile, based on publicly available information

Anthi Panara

Laboratory of Analytical Chemistry Department of Chemistry National and Kapodistrian University of Athens Athens Greece

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

27 November 2025 in Plant Cell Reports
Verified
Journal Article
Closed access
PDF file
DTDikran Tsitsekian
Dikran Tsitsekian
GDGerasimos Daras
Gerasimos Daras
APAnthi Panara
Anthi Panara
Anastasios AlatzasAnastasios Alatzas
Anastasios Alatzas
AKAnastasia Koupa
Anastasia Koupa
SRStamatis Rigas
Stamatis Rigas

11 May 2023 in Mediterranean Marine Science
Verified
Journal Article
Open access
PDF file
MKManto Kotsiri
Manto Kotsiri
APAnthi Panara
Anthi Panara
AKAnastasia Koupa
Anastasia Koupa
EGEvgenia Gourzioti
Evgenia Gourzioti
Nikolaos ThomaidisNikolaos Thomaidis
Nikolaos Thomaidis
GRGeorge Rigos
George Rigos
This study was performed to measure the possible persistence of formaldehyde, the active substance of formalin solution, in seawater and edible gilthead seabream (Sparus aurata) tissues after a formalin bath. The trial was carried out during the summer period as parasitic infestations are of a high frequency. Water samples were taken within or at a short distance from the treatment cages, during and following formalin immersion. Fish fillets were also sampled at the same sampling points. Chromatographic analysis of water and tissue samples was performed with a photodiode array detector (HPLC-PDA). Measured formaldehyde concentrations in gilthead seabream fillets clearly showed no increase due to the immersion or advent of time. Formaldehyde measurements in seawater revealed that after formalin treatments negligible amounts of the substance remain in the aquatic environment and these values seem to be relatively unaffected by depth in the vicinity of the fish cages. Further research is required to investigate the formalin degradation cycle under Mediterranean seawater conditions, including more farm sites and temperature ranges.

4 June 2026 in RSC Medicinal Chemistry
Verified
Journal Article
Open access
PDF file
IKIoanna Kalpaktsi
Ioanna Kalpaktsi
APAnthi Panara
Anthi Panara
BMBarbara Mavroidi
Barbara Mavroidi
GNGiorgos Garcia Niforos
Giorgos Garcia Niforos
AKAmalia Kalampaliki
Amalia Kalampaliki
Ioannis KostakisIoannis Kostakis
Ioannis Kostakis
Hydroxytyrosol-derived esters emerge as stable oleuropein mimetics that inhibit Aβ aggregation and confer in vivo neuroprotection.

28 August 2026 in ChemMedChem
Verified
Journal Article
Open access
PDF file
ETEfstratios Tsakalidis
Efstratios Tsakalidis
MGMariangela Giannouli
Mariangela Giannouli
IAIfigeneia Akrani
Ifigeneia Akrani
APAnthi Panara
Anthi Panara
EKEleni Katalagarianou
Eleni Katalagarianou
VMVassilios Myrianthopoulos
Vassilios Myrianthopoulos
The tandem Tudor domain (TTD) of UHRF1 is a compelling epigenetic target for novel cancer therapeutics. Here, we integrate theoretical simulations, sophisticated biophysical evaluations and cellular assays to characterize potent TTD binders. Screening of small drug‐ and fragment‐like collections identifies several TTD ligands, with the most promising hit being the local anesthetic hydroxyprocaine. The ligand is characterized in terms of its binding requisites by calorimetry, affording a K d of 1.46 μM and a well‐balanced thermodynamic profile. Molecular dynamics simulations combined with heat capacity measurements and osmotic stress titrations confirm that hydroxyprocaine binds stably to the TTD by displacing approximately 26 interfacial water molecules upon complexation. A targeted follow‐up screen focusing on sodium channel blockers yields two additional, although less promising hits, mexiletine and triamterene. In the DU145 prostate cancer cell line, hydroxyprocaine treatment significantly up‐regulates key downstream targets including the tumor‐suppressor p53 and, to a lesser degree, the stress and inflammation regulators p38 and p65, respectively, while exhibiting very low cytotoxicity. Finally, a previously undocumented interdomain interaction between TTD and its N‐terminal adjacent Ubiquitin‐like domain is reported, introducing a novel, potentially druggable UHRF1 regulatory feature. Together, these findings establish hydroxyprocaine as a highly viable chemical scaffold for TTD‐targeted drug development.

9 November 2026 in Microchemical Journal
Verified
Journal Article
Closed access
DSDimitris Sakkas
Dimitris Sakkas
APAnthi Panara
Anthi Panara
AEAristides G. Eliopoulos
Aristides G. Eliopoulos
NTNikolaos S. Thomaidis
Nikolaos S. Thomaidis
Evangelos GikasEvangelos Gikas
Evangelos Gikas